Update on the Management of Vitiligo
Skin Therapy Letter
Vitiligo is an acquired, autoimmune disease characterized by depigmented macules and patches on the skin, which occur secondary to melanocyte destruction. Available therapeutic options are broadly divided into medical, surgical and phototherapy, though treatment of vitiligo can be challenging. Early diagnosis and management can maximize treatment efficacy. The purpose of this discussion is to review updates in the management of vitiligo, including existing and emerging therapies.
Nahhas AF, Braunberger TL, Hamzavi IH. Update on the Management of Vitiligo. Skin Therapy Lett. 2019 May;24(3):1-6. PMID: 31095346.